Elixinol was founded by a group of passionate leaders committed to bringing forth education and awareness on how people can live long, healthy lives and to naturally reduce the amount of disease we see in our world today.
Co-Founder Paul Benhaim has been a global leader in the Industrial Hemp industry, having actively been involved since 1991. Over the course of the last few decades he has built deep relationships with the top experts in the world who have been using hemp for multiple purposes. He is the founder of globally recognized Hemp Foods Australia and has been cultivating and manufacturing Hemp on a large scale around the world.
Because of some of the latest research by leading scientists into the powerful impact the Cannabinoids in the Hemp plant can have on human health and Paul’s background and deep connections as a worldwide authority on the cultivation of hemp, many influential people around the world began reaching out to him about developing Cannabinoid based products.
2 Websites for Your Reviewing Information
The X-Pen is a revolutionary dispensing system exclusive to Elixinol.
Our standardized whole plant Hemp extract means you get the same dependable formula in the same synergistic natural form your body prefers – every press, every pen, every time.
Bern, Switzerland: Electronically powered vaporizers deliver cannabinoids in a relatively safe and reliable manner, according to data published in the journal PLOS ONE.
Swiss investigators evaluated the ability of various types of vaporizer technologies to safely and effectively release THC and CBD (cannabidiol) in vapor. Researchers reported that electronically driven devices, which allow for precise temperature control, provided relatively safe and uniform dosing. By contrast, gas-powered devices performed in a more unreliable manner and “cannot be recommended for therapeutic purposes.”
Authors concluded, “[T]he four electrically-driven and temperature-controlled vaporizers investigated in this study efficiently decarboxylate acidic cannabinoids and release reliably the corresponding neutral cannabinoids into the vapor. Therefore, they can be considered as a promising application mode for the safe and efficient administration of medicinal cannabis and cannabinoids.”
Vaporizer technology heats herbal marijuana to a point where cannabinoid vapors form, but below the point of combustion. In clinical trials, investigators have concluded that vaporization “does not result in exposure to combustion gases” and produces higher plasma concentrations of THC compared to smoked cannabis.
For more information, please contact Paul Armentano, NORML Deputy Director, at: email@example.com. Full text of the study, “Medicinal Cannabis: In vitro validation of vaporizers for the smoke-free inhalation of cannabis,” appears online in PLOS ONE.
Full Article & NormL website: http://norml.org/news/2016/01/28/study-vaporizers-deliver-safe-reliable-doses-of-cannabinoids